Hoppa till innehåll
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Språk
Alla fält
Titel
Upphovsman
Ämne
Signum
ISBN/ISSN
Tagg
Sök
Avancerad
Emerging biologics in severe a...
Hänvisa
Textmeddelande
Skicka per e-post
Skriv ut
Exportera posten
Exportera till: RefWorks
Exportera till: EndNoteWeb
Exportera till: EndNote
Permanent länk
Emerging biologics in severe asthma
Bibliografiska uppgifter
Huvudupphovsmän:
Pavord, I
,
Hilvering, B
,
Shrimanker, R
Materialtyp:
Journal article
Publicerad:
Elsevier
2016
Beståndsuppgifter
Beskrivning
Liknande verk
Katalogiseringsuppgifter
Liknande verk
Interleukin-5 inhibitors for severe asthma: Rationale and future outlook.
av: Shrimanker, R, et al.
Publicerad: (2017)
Evidence for the efficacy and safety of anti- interleukin-5 treatment in the management of refractory eosinophilic asthma
av: Xue, L, et al.
Publicerad: (2015)
Management and mechanisms of severe eosinophilic asthma
av: Shrimanker, R
Publicerad: (2020)
Exacerbations of severe asthma in patients treated with mepolizumab
av: Shrimanker, R, et al.
Publicerad: (2018)
Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo
av: Howell, I, et al.
Publicerad: (2024)